Author Topic: (Abst.) Are disease-modifying drugs for progressive MS worthwhile?  (Read 59 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9822
  • MS diagnosed 1980
  • Location: Pacific Northwest
From PubMed via Multiple Sclerosis and Related Disorders (July 3, 2021)--"Delaying the inevitable: Are disease-modifying drugs for progressive multiple sclerosis worthwhile?"


The article concerns siponimod and ocrelizumab. This will also be posted in the Mayzent (siponimod) section.



https://pubmed.ncbi.nlm.nih.gov/34247107/
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
109 Views
Last post May 16, 2017, 11:42:43 am
by agate
0 Replies
112 Views
Last post June 01, 2017, 02:12:21 pm
by agate
0 Replies
82 Views
Last post December 13, 2017, 02:44:44 pm
by agate
0 Replies
51 Views
Last post July 12, 2021, 02:33:26 pm
by agate
0 Replies
24 Views
Last post June 16, 2022, 09:20:56 pm
by agate